image credit: Unsplash

Mass. Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing

July 29, 2020


Massachusetts’ top-tier biopharma cluster is weathering the storm wreaked by COVID-19 after a year in which it continued to attract jobs, especially R&D jobs,and venture capital (VC) investment—helping to keep the Bay State on top in two key measures of growth, according to a report issued this week by the statewide life sciences industry group.

The Bay State’s biopharma workforce grew 7.7% last year to a total 79,972 jobs, up from 74.256 in 2018, the Massachusetts Biotechnology Council (MassBio) reported in its 2020 Industry Snapshot, produced in partnership with Evaluate.

Read More on Genetic Engineering and Biotechnology News